Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5827 results
Celgene expands bispecific antibody collaboration with Zymeworks
Zymeworks said that Celgene has exercised its right to expand its collaboration agreement for the research, development, and commercialization of bispecific antibody therapeutics using the former’s Azymetric platform.
Drug Research > Drug Discovery & Development > News
Scientists develop new method to make drugs smarter
Scientists from the University of Lincoln in the UK have created a new technique using nanotechnology which can make drugs more effective at reaching their target.
Drug Research > Drug Discovery & Development > News
Managing your weight never tasted so good! New weight loss gummies,Visit us at booth E24 at Vitafoods 2018.
Nutrition is a trending topic for consumers today, but taste, convenience, and ease of use are also influencing purchasing decisions. With such demands from discerning consumers increase, and summer just around the corner, everybody is focused on getting their body in the best possible shape.
Drug Research > Drug Discovery & Development > Press Releases
Biogen to pay Ionis $1bn for neurological drugs development
By PBR Staff Writer
Biogen has entered into a new ten-year collaboration agreement with Ionis Pharmaceuticals for the development of antisense drug candidates to treat a range of neurological diseases.
Drug Research > Drug Discovery & Development > News
Tmunity raises another $35m to advance T Cell therapies
Tmunity Therapeutics, a biotherapeutics company focused on developing next-generation T cell immunotherapy, has raised new funding of $35m in a Series A investment from Kleiner Perkins and affiliates.
Drug Research > Drug Discovery & Development > News
Shire rejects $63bn takeover proposal from Takeda
By PBR Staff Writer
Ireland-based Shire has rejected a $63bn acquisition offer from Takeda Pharmaceutical, saying that it undervalues the company, its growth prospects and pipeline.
Drug Research > Drug Discovery & Development > News
BenevolentAI raises $115m to advance AI-enabled drug development activities
By PBR Staff Writer
BenevolentAI has secured $115m funding to advance drug development activities and extend its artificial intelligence (AI) platform capabilities.
Drug Research > Drug Discovery & Development > News
Sandoz, Pear to commercialize prescription digital therapeutics
Sandoz, a division of Novartis, and Pear Therapeutics have agreed to jointly commercialize and continue development of novel prescription digital therapeutics designed to treat disease and improve clinical outcomes for patients.
Drug Research > Drug Discovery & Development > News
Catabasis Pharmaceuticals to reduce workforce by about 42%
Catabasis Pharmaceuticals is restructuring its resources to focus on late-stage lead program, edasalonexent, for the treatment of Duchenne muscular dystrophy (DMD).
Drug Research > Drug Discovery & Development > News
Novartis to invest $100m into antimalarials research
Novartis said that it will invest more than $100m to advance research and development of new antimalarials over the next five years.
Drug Research > Drug Discovery & Development > News
Kalytera scraps pre-clinical programs in bone disease
Kalytera Therapeutics has announced the termination of its pre-clinical development programs in the treatment of bone disease to focus its resources on graft versus host disease (GVHD) and pain programs.
Drug Research > Drug Discovery & Development > News
Inovio secures $56m from CEPI to advance DNA vaccines against Lassa fever and MERS
Inovio Pharmaceuticals has secured funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop vaccine candidates against Lassa fever and Middle East Respiratory Syndrome (MERS).
Drug Research > Drug Discovery & Development > News
Orchard Therapeutics to buy GSK’s rare disease gene therapy portfolio
By EBR Staff Writer
Privately held clinical-stage biotechnology firm Orchard Therapeutics has agreed to acquire the rare disease gene therapy portfolio of GlaxoSmithKline (GSK).
Drug Research > Drug Discovery & Development > News
Mylan bags license to commercialize Fujifilm's Humira biosimilar in Europe
Mylan has acquired an exclusive license to commercialize a biosimilar to Humira (adalimumab), developed by Fujifilm Kyowa Kirin Biologics, in Europe.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Discovery & Development > Suppliers
Patient Focused Medicines Development (PFMD)
Patients Focused Medicine Development (PFMD) is an open, global and collaborative coalition of patient organisations and advocates, pharma and life sciences industry, HTA bodies, national advisory organisations and regulators. Their aim is to drive meaningful patient engagement by co-creating a standardised and globally adopted framework for patient engagement, so that patients' needs and priorities are at the core of medicines development and lifecycle. PFMD was established in 2015 and currently counts 24 members. Their 'Pledge to Patients' campaign encourages members of the medical community to commit to measurable actions to improve patient engagement.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

LTS Broschüre - Deutsche Version By Lohmann Therapy System
Am Anfang jedes Erfolgs steht eine Vision. Eine Idee, die etwas verändern soll. Ein Ziel, das man niemals aus den Augen verliert.... Drug Research > Drug Discovery & Development > White Papers LTS Brochure - English Version By Lohmann Therapy System
Success starts with a vision. An idea that will make a difference. A goal you never lose sight of. At LTS, this goal has always been clear: To offer alternatives to patients who experience discomfort, swallowing difficulties or undesirable side effects caused by conventional dosage forms.... Drug Research > Drug Discovery & Development > White Papers Vetter: A unique blend of expertise By Vetter Pharma International
From clinical development to commercial production.... Drug Research > Drug Discovery & Development > White Papers Vetter Development Service - Supporting your compound’s success By Vetter Pharma International
A unique blend of expertise for clinical manufacturing.... Drug Research > Drug Discovery & Development > White Papers Vetter Commercial Manufacturing - Delivering results across the production chain By Vetter Pharma International
A unique blend of capabilities for aseptic fill and finish.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5827 results